Fibroblasts could serve as new key to enhancing personalized treatment for lung cancer patients
Researchers have identified three functional subtypes of these cells, which correspond to patients’ treatment response.
About Zosia Piotrowska, MD, MHS
Clinical Interests:
- Clinical trials, clinical research
- Epidermal growth factor receptor mutation
- Lung cancer
- Targeted therapies
Treats:
- Adult
Languages:
- French, Polish
Locations
Mass General Cancer Center: Thoracic Oncology
55 Fruit St.
Boston, MA 02114
Phone: 877-726-5130
Medical Education
- MD, Yale University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Dana Farber Cancer Institute
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.